Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment

Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment

Overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) has improved in the era of multi-line sequential therapy. The application of antiviral therapy and its impact on survival for patients with HBV-related HCC needs to be reassessed. The aim of this study was to evaluate the...

Full description

Bibliographic Details
Main Authors: I-Cheng Lee, Pei-Chang Lee, Yee Chao, Chen-Ta Chi, Chi-Jung Wu, Yi-Ping Hung, Chien-Wei Su, Ming-Chih Hou, Yi-Hsiang Huang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
hepatitis B virus
hepatocellular carcinoma
tyrosine kinase inhibitor
antiviral therapy
sorafenib
lenvatinib
Online Access:https://www.mdpi.com/1999-4915/14/11/2355

Internet

https://www.mdpi.com/1999-4915/14/11/2355

Similar Items